Corticosteroids and Surfactant for Prevention of Neonatal RDS

References

• Jobe A, Ikegami M. Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis 1987; 136: 1256–75
   PubMed Web of Science ®Google Scholar
• Hallman M, Merritt A, Pohjavuori M, Gluck L. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship of severity of respiratory failure. Pediatr Res 1986; 20: 1228–35
   PubMed Web of Science ®Google Scholar
• Ikegami M, Jobe A, Berry D. A protein that inhibits surfactant in respiratory distress syndrome. Biol Neonate 1986; 50: 121–9
   PubMedGoogle Scholar
• Jobe A. Respiratory distress syndrome-new therapeutic approaches to a complex pathophysiology. Adv Pediatr 1984; 30: 93–130
   Google Scholar
• Liggins G C., Howie R N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515–25
   PubMed Web of Science ®Google Scholar
• Liggins G C. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 1969; 45: 515–23
   PubMed Web of Science ®Google Scholar
• Crowley P, Chalmers I, Keirse M JNC. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990; 97: 11–25
   PubMedGoogle Scholar
• Soil R F. Surfactant replacement therapy: overview of clinical trials. Int Proc J 1991; 1: 29–39
   Google Scholar
• Smith B T. Lung maturation in the fetal rat: acceleration by injection of fibroblast-pneumonocyte factor. Science 1979; 204: 1094–5
   PubMed Web of Science ®Google Scholar
• Post M, Barsoumian A, Smith B T. The cellular mechanism of glucocorticosteroid acceleration of fetal lung maturation: fibroblast-pneumonocyte factor stimulates cholinephosphate cytidylyltransferase activity. J Biol Chem 1986; 261: 2179–85
   PubMed Web of Science ®Google Scholar
• Post M. Maternal administration of dexamethasone stimulates cholinephosphate cytidylyltransferase in fetal type II cells. Biochem J 1987; 241: 291–6
   PubMed Web of Science ®Google Scholar
• Schellhase D E., Shannon J M. Effects of maternal dexamethasone expression of SP-A, SP-B and SP-C in the fetal rat lung. Am J Respir Cell Mol Biol 1991; 4: 304–12
   PubMed Web of Science ®Google Scholar
• Phelps D S., Church S, Kourembanas S, Taeusch H W., Floras J. Increases in the 35 kDa surfactant-associated protein and its mRNA following in vivo, dexamethasone treatment of fetal and neonatal rats. Electrophoresis 1987; 8: 235–8
   Web of Science ®Google Scholar
• Liley H G., White R T., Warr R G., Benson B J., Hawgood S, Ballard P L. Regulation of messenger RNAs for the hydrophobic surfactant proteins in human lung. J Clin Invest 1989; 83: 1191–7
   PubMed Web of Science ®Google Scholar
• Whltsett J A., Weaver T E., Clark J C., et al. Glucocorticoid enhances proteolipid Phe and pVal synthesis and mRNA in fetal lung. J Biol Chem 1987; 262: 15618–23
   PubMedGoogle Scholar
• Cheng J B., Goldfien A, Ballard P L., Roberts J M. Glucocorticoids increase pulmonary β-adrenergic receptors in fetal rabbit. Endocrinology 1980; 107: 1646–8
   PubMed Web of Science ®Google Scholar
• Beck J C., Mitzner W, Johnson J WC, et al. Betamethasone and the rhesus fetus: effect on lung morphometry and connective tissue. Pediatr Res 1981; 15: 235–40
   PubMed Web of Science ®Google Scholar
• Grossmann G, Nllsson R, Robertson B. Scanning electron microscopy of epithelial lesions induced by artificial ventilation of the immature neonatal lung; the prophylactic effect of surfactant replacement. Eur J Pediatr 1986; 145: 361–7
   PubMed Web of Science ®Google Scholar
• Ikegaml M, Jobe A H., Seldner S, Yamada T. Gestational effects of corticosteroids and surfactant in ventilated rabbits. Pediatr Res 1989; 25: 32–7
   PubMedGoogle Scholar
• Ikegami M, Jobe A H., Yamada T, Seidner S. Relationship between alveolar saturated phosphatidylcholine pool sizes and compliance of preterm rabbit lungs. Am Rev Respir Dis 1989; 139: 367–9
   PubMed Web of Science ®Google Scholar
• Cosmi E V., Anceschl M M. New advances in prenatal prevention of respiratory distress syndrome of the neonate. Surfactant in clinical practice., G Bevilacqua, S Parmigiani, B Robertson. Harwood, Chur 1993; 217–21
   Google Scholar
• Fujiwara T, Robertson B. Pharmacology of exogenous surfactant. Pulmonary surfactant from molecular biology to clinical practice., B Robertson, G van, L MG olde, J J. Batenburg. Elsevier, Amsterdam 1992; 561–92
   Google Scholar
• Fiascone J M., Jacobs H C., Moya F R., Mercurio M R., Lima D M. Betamethasone increases pulmonary compliance in part by surfactant-independent mechanisms in preterm rabbits. Pediatr Res 1987; 22: 730–5
   PubMed Web of Science ®Google Scholar
• Anceschl M M., Robertson B, Broccucci L, et al. Immunochemical and immunohistochemical evaluation of lung permeability in ventilated newborn rabbits. Exp Lung Res 1990; 16: 593–605
   PubMedGoogle Scholar
• Anceschl M M., Robertson B, Broccucci L, Luzi P, Zaccardo G, Cosml E V. (1990) Effect of Curosurf on lung permeability in immature newborn rabbits. Proceedings of 5th International Workshop on Surfactant Replacement, Sestri Levante. 1990, G Bevilacqua, B Robertson. Chiesi Farmaceutici, Parma, 72–7
   Google Scholar
• Robertson B, Berry D, Curstedt T, et al. Leakage of protein in the immature rabbit lung; effect of surfactant replacement. Respir Physiol 1985; 61: 265–76
   PubMedGoogle Scholar
• Jobe A, Ikegami M, Jacobs H, Jones S, Conaway D. Permeability of premature lamb lungs to protein and the effect of surfactant on that permeability. J Appl Physiol 1983; 55: 169–76
   PubMed Web of Science ®Google Scholar
• Farrell E E., Silver R K., Klmberlin L V., Wolf E S., Dusik J M. Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants. Am J Obstet Gynecol 1989; 161: 628–33
   PubMed Web of Science ®Google Scholar
• Egberts J, de Winter J P., Sedin G, et al. Comparison of prophylaxis and rescue treatment with Curosurf in babies less than 30 weeks gestation. A randomized trial. Pediatrics, (in press)
   Google Scholar
• Ikegami M, Berry D, Elkady T, Pettenazzo A, Seidner S, Jobe A. Corticosteroids and surfactant change lung function and protein leaks in the lungs of ventilated premature rabbits. J Clin Invest 1987; 79: 1371–8
   PubMed Web of Science ®Google Scholar
• Seidner S, Pettenazzo A, Ikegami M, Jobe A. Corticosteroid potentiation of surfactant dose response in preterm rabbits. J Appl Physiol 1988; 64: 2366–71
   PubMed Web of Science ®Google Scholar
• Ikegami M, Jobe A H., Pettenazzo A, Seidner S R., Berry D D., Rufflni L. Effects of maternal treatment with corticosteroids, T3, TRH, and their combinations on lung function of ventilated preterm rabbits with and without surfactant treatments. Am Rev Respir Dis 1987; 136: 892–8
   PubMed Web of Science ®Google Scholar
• Warburton D, Parton L, Buckley S, Cosico L, Enns G, Saluna T. Combined effects of corticosteroid, thyroid hormones, and β-agonist on surfactant, pulmonary mechanics, and β-receptor binding in fetal lamb lung. Pediatr Res 1988; 24: 166–70
   PubMed Web of Science ®Google Scholar
• Ballard R A., Ballard P L., Creasy R K., et al. Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. Lancet 1992; 339: 510–5
   PubMed Web of Science ®Google Scholar